Clinical Trials Logo

Dermatitis, Atopic clinical trials

View clinical trials related to Dermatitis, Atopic.

Filter by:

NCT ID: NCT01897506 Completed - Asthma Clinical Trials

Assessing Risk of Food Insecurity Within Households of Children With Food Allergy

Start date: June 2013
Phase:
Study type: Observational

Our central hypothesis is that dietary limitations introduced by food allergy will contribute to increased food insecurity in households with food allergic children when compared to food insecure households without food allergic children.

NCT ID: NCT01861548 Completed - Asthma Clinical Trials

Polish Mother and Child Cohort Study (REPRO_PL) - Follow up of the Children.

REPRO_PL
Start date: January 2007
Phase: N/A
Study type: Observational

The Polish Mother and Child Cohort is multicentre prospective study on different exposures. Prospective cohort study design enables identification of exposures that may influence pregnancy outcome and chil-dren's health, verification of such exposures by biomarker measurements and notification of any changes in exposure levels. The aim of the study is to evaluate the impact of exposure to different environmental factors during pregnancy and after birth on pregnancy outcome and children's health. Specific research hypotheses refer to the role of heavy metals, exposure to polycyclic aromatic hydrocar-bons (PAHs) and environmental tobacco smoke (ETS) in the aetiology of intrauterine growth retardation (IUGR), preterm delivery (PD) and the risk of respiratory diseases, allergy and poor mental and physical development. It is also intended to explain the role of oxidative stress and nutritional status of the pregnant women. The impact of occupational exposures and stressful situations on pregnancy outcome will be evaluated from question-naire data. The results of the study will help to determine levels of child prenatal and postnatal exposure in several areas of Poland and their im-pact on course and outcome of pregnancy and children's health. This protocol concerns the children that are followed-up from birth to the age of 2 years to determine long term effects of pre- and postnatal environmental exposures.

NCT ID: NCT01859988 Completed - Atopic Dermatitis Clinical Trials

Study of Dupilumab (REGN668/SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Start date: May 2013
Phase: Phase 2
Study type: Interventional

To assess the efficacy of multiple dupilumab (REGN668/SAR231893) dose-regimens, compared to placebo, in adult patients with moderate-to-severe atopic dermatitis (AD).

NCT ID: NCT01856764 Completed - Atopic Dermatitis Clinical Trials

Topical Roflumilast in Adults With Atopic Dermatitis

Start date: June 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effect of topical roflumilast on the reduction of atopic dermatitis lesions in adults with atopic dermatitis.

NCT ID: NCT01854580 Completed - Depression Clinical Trials

Evaluation of an Integrated Care Project

ediva
Start date: March 2013
Phase:
Study type: Observational

The purpose of the study is to investigate the effectiveness and cost-effectiveness of the integrated care program of a statutory health insurance offering additional homeopathic treatment to their members

NCT ID: NCT01850849 Completed - Atopic Dermatitis Clinical Trials

Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream

Start date: May 2013
Phase: Phase 1
Study type: Interventional

The principle aim of this study is to obtain safety, tolerability and pharmacokinetic data when LEO 39652 cream is administered cutaneously as single dose to subjects with atopic dermatitis and to healthy subjects.

NCT ID: NCT01840605 Completed - Dermatitis Clinical Trials

A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis

Start date: March 2013
Phase: Phase 3
Study type: Interventional

The objective of this study is to verify the non-inferiority of TAU-284 to ketotifen fumarate dry syrup in the change in the severity of pruritus after the treatment period.

NCT ID: NCT01828879 Completed - Dermatitis, Atopic Clinical Trials

An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis

Start date: November 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of tacrolimus ointment in treating the signs and symptoms of moderate (medium level of seriousness) to severe (very serious, life threatening) atopic dermatitis (an intensely pruritic [itching], chronic [lasting a long time], inflammatory [pain and swelling], immunologically based skin disease with a genetic predisposition [latent susceptibility to disease at the genetic level]) in adult participants.

NCT ID: NCT01826630 Terminated - Atopic Dermatitis Clinical Trials

A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema

Start date: July 2013
Phase: N/A
Study type: Interventional

The primary objective of this protocol is to acquire pilot data for a larger study to test the following hypothesis: Treatment of the hands of patients with chronic hand dermatitis/atopic dermatitis with CLn BodyWash, a novel gel wash cleanser currently marketed as a cosmetic product containing a dilute concentration of less than 0.01% sodium hypochlorite and less than 0.005% concentration as it is lathered, will result in a statistically significant reduction in the number of skin fauna present on the hands of these patients compared to treatment of such patients with traditional wash used clinically such as Cetaphil Daily Facial Cleanser.

NCT ID: NCT01826461 Completed - Atopic Dermatitis Clinical Trials

An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis

Start date: March 2013
Phase: Phase 2
Study type: Interventional

This study will compare the safety and efficacy of three test article foams (PDI-192 0.1% Foam, PDI-192 0.15% Foam, and Vehicle Foam) such that a final commercial product may be selected for future development.